The Open Cancer Immunology Journal

2009, 2 : 10-17
Published online 2009 November 10. DOI: 10.2174/1876401000902010010
Publisher ID: TOCIJ-2-10

Hydroxyl Radical Damaged Thymidine-5’-Monophophate Presents Unique Epitopes for Cancer Antibodies

Rizwan Ahmad , Zafar Rasheed and Rashid Ali
Department of Pathology, Microbiology & Immunology, School of Medicine, University of South Carolina, 6439 Garners Ferry Road, Columbia, SC 29209, USA

ABSTRACT

Reactive oxygen species (ROS) plays an important role in carcinogenesis and hydroxyl radical (.OH) contributes to the structural changes in DNA that characterize the cancer like phenotype. The role of hydroxyl radical (.OH) damaged thymidine 5'-monophosphate (TMP) in cancer patients has been investigated in the present study. TMP was conjugated to bovine serum albumin (BSA), and then TMP-BSA conjugate was modified by hydroxyl radicals. Cancer patients (n = 99) were screened by direct binding ELISA for the detection of antibodies against native and ROS-modified conjugates and the results were compared with healthy age-matched controls (n = 29). High degree of specific binding by cancer serum antibodies towards ROS modified TMP-BSA conjugate, in comparison to unmodified conjugate (p<0.05) was observed. Healthy individuals showed negligible binding with either antigen. Competitive inhibition ELISA reiterates the direct binding results. Protein-A affinity purified IgG from cancer patients further substantiated the enhanced recognition towards modified conjugate as compared to unmodified conjugate. The present study clearly shows the perturbation in TMP-BSA conjugate by hydroxyl radical presenting unique neo-epitopes on TMP that might from one of the factors in antigen driven induction of antibodies in cancer patients.

Keywords:

Pharmacoeconomic analysis, CHOP, R-CHOP, rituximab, B-cell non-Hodgkin lymphoma.